Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Jagsonpal Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:507789NSE Symbol: JAGSNPHARMP/E(TTM):26.55
ISIN Demat:INE048B01035Div & Yield %:1.47EPS(TTM):6.37
Book Value(Rs):37.8067557Market Cap ( Cr.):1131.45Face Value(Rs):2
    Change Company 
Date Headline
22-Jan-26 Jagsonpal Pharmaceuticals standalone net profit declines 65.77% in the December 2025 quarter
14-Jan-26 Jagsonpal Pharmaceuticals schedules board meeting
06-Jan-26 Jagsonpal Pharmaceuticals allots 1.09 lakh equity shares under ESOP
18-Nov-25 Jagsonpal Pharmaceuticals allots 56,571 equity shares under ESOP
07-Nov-25 Jagsonpal Pharmaceuticals Ltd - Jagsonpal Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updat..
04-Nov-25 Jagsonpal Pharmaceuticals standalone net profit rises 9.69% in the September 2025 quarter
28-Oct-25 Jagsonpal Pharmaceuticals to declare Quarterly Results
08-Oct-25 Jagsonpal Pharma appoints Nirav Vora as CFO
08-Oct-25 Jagsonpal Pharmaceuticals Ltd - Jagsonpal Pharmaceuticals Limited - Updates
07-Oct-25 Jagsonpal Pharmaceuticals allots 93,445 equity shares under ESOP
<< < 1 2 3 4   > >>